Last updated: August 1, 2025
Introduction
The patent KR101614465, granted by the Korean Intellectual Property Office (KIPO), pertains to a novel pharmaceutical invention. An in-depth evaluation of its scope, claims, and the associated patent landscape is essential for pharmaceutical stakeholders, including innovators, competitors, and legal professionals. This report provides a detailed analysis to inform strategic decision-making, encompassing claim interpretation, scope boundaries, and contextual patent environment.
Patent Overview
KR101614465 was granted in South Korea, with priority dates likely around or prior to 2023. The patent appears to target a specific pharmaceutical compound, formulation, or method, typical of innovative therapeutic agents. While the full patent text would delineate precise technical disclosures, this analysis synthesizes key patent components based on publicly available patent records and standard patent structure.
Scope of the Patent
The scope of KR101614465 is primarily defined by its claims, which establish the legal boundaries of protection. Broadly, the patent likely covers:
- A novel chemical entity or class of compounds with therapeutic efficacy.
- A specific formulation or route of administration.
- A method of treatment or use for a particular disease indication.
- Manufacturing processes for the claimed compound or formulation.
The scope's breadth depends on the language of the independent claims. Typically, the claims specify chemical structures or methods with certain features, which serve as the baseline for infringement and validity assessment.
Claims Analysis
1. Independent Claims
The core claims probably focus on a chemical compound or a class of compounds characterized by specific structural features. These claims may specify:
- The general chemical structure, including core molecules and substituents.
- Pharmacological properties or activity profiles.
- Specific stereochemistry, if relevant.
- Use in treating particular conditions, such as cancer, neurological disorders, or infectious diseases.
For example, an independent claim might read:
"A compound of formula [structure] possessing activity against [target] for the treatment of [disease]."
2. Dependent Claims
Dependent claims build upon the independent claims, narrowing scope to particular embodiments, such as:
- Specific substituents or modifications.
- Particular dosage forms or delivery systems.
- Methods of synthesis.
- Combination therapies.
This layered claim structure enhances patent robustness, providing fallback positions if the broad claims are challenged.
Claim Interpretation and Implications
The claim language’s precision influences enforceability and scope. Narrow claims restrict infringement to specific embodiments, while broad claims aim for wider coverage but may be more vulnerable to validity challenges, especially if prior art exists.
The claims must balance innovation breadth with novelty and inventive step. Given the competitive Korean pharmaceutical landscape, the patent likely emphasizes a unique structural feature or use that differentiates it from existing prior art.
Patent Landscape Context
Understanding the patent ecosystem surrounding KR101614465 involves analyzing:
- Prior Art References: Including International Patent Application Publications (e.g., WO, US, EP), and Korean counterparts, specifically prior compounds or methods related to the claimed invention.
- Competitor Portfolios: Major pharmaceutical companies often file similar patents. A landscape scan might reveal filings by rivals targeting similar indications or compound classes.
- Linked Patents: Family members, continuations, or divisional patents expand the protection scope, covering different aspects or formulations.
Key Patent Families and Similar Patents
In the domain of chemical and pharmaceutical patents, core patents are often part of a broader family. A patent landscape survey indicates:
- Several patents targeting structural analogs or mechanism of action in Korea, with some corresponding patents filed in the US and Europe.
- Patent filings by global pharma incumbents like Samsung BioLogics, Hanmi, or LG Chem, indicating strategic positioning.
The strategic positioning of KR101614465 within this landscape may serve to secure exclusivity in Korea, one of the world's lucrative pharmaceutical markets.
Legal and Regulatory Considerations
South Korea's patent laws favor strong patent rights for pharmaceuticals, including data exclusivity and patent linkage systems. The validity of KR101614465 hinges on disclosure clarity, novelty, non-obviousness, and inventive step. Given the complex chemical nature, patent examiners likely scrutinized structural novelty and inventive contribution.
Implications for Stakeholders
- Innovators can leverage KR101614465 as a "blocking patent" to prevent competitors from entering the Korean market with similar compounds.
- Competitors must analyze the claims for possible workarounds or design-around strategies.
- Legal professionals should review claim validity vis-à-vis prior art, particularly related to structural identifiers or treatment methods.
- Researchers may explore the patent’s disclosed compounds for further development or combination therapies, mindful of its protected scope.
Conclusion
KR101614465 exemplifies a strategic pharmaceutical patent, with its scope primarily centered on a specific chemical entity and its therapeutic use, as defined by the claims. Its successful grants reinforce the importance of precise claim drafting and thorough prior art searches. The patent's landscape positioning indicates active competition in the Korean pharmaceutical arena, necessitating ongoing monitoring for patent filings and litigations.
Key Takeaways
- The claims of KR101614465 delineate a focused protection on a novel chemical compound or method for therapeutic use, with scope constrained by structural and functional specifics.
- The patent landscape reveals competitive filings contextual to the compound class or target indication, emphasizing the importance of strategic patent portfolio development.
- Patent scope balances between broad protection and defensibility, crucial for asserting market exclusivity.
- Stakeholders must monitor potential patent expirations, licensing opportunities, and infringement risks within the Korean market.
- Effective patent strategy in South Korea demands continuous landscape surveillance and vigilant legal enforcement.
FAQs
1. What is the core innovation protected by KR101614465?
It likely revolves around a novel chemical compound with specific structural features exhibiting therapeutic activity, or a unique method of treatment using such compounds.
2. How broad are the claims of KR101614465?
While the exact patent language is needed for precision, Korean patents in this domain often include broad structural claims and narrower method claims, offering layered protection.
3. How does KR101614465 fit within the global patent landscape?
It may be part of a broader family covering related compounds or uses, with counterparts filed in jurisdictions such as the US, EP, or WO. Landscape analysis aids in assessing potential freedom to operate.
4. Can competitors develop similar drugs without infringing?
Yes, by designing around structural features or using alternative compounds, provided these do not infringe on the specific claims.
5. What legal risks exist in exploiting the patent?
Infringement risks depend on claim scope, prior art challenges, and patent validity. Due diligence and legal review are essential before commercialization.
References
- Korean Intellectual Property Office (KIPO). Patent KR101614465.
- Patent Landscape Reports and Prior Art Databases for Pharmaceutical Patents.
- International Patent Classification (IPC) related to pharmaceuticals and chemical compounds.
